COVID-19 Impact on Global Anti-Infective Medications Market Insights, Forecast to 2026
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-Infective Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Infective Medications industry.
Based on our recent survey, we have several different scenarios about the Anti-Infective Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Infective Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Infective Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Infective Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Anti-Infective Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Anti-Infective Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-Infective Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-Infective Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Infective Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Infective Medications market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-Infective Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Infective Medications industry.
Based on our recent survey, we have several different scenarios about the Anti-Infective Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Infective Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Infective Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Infective Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Anti-Infective Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Anti-Infective Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-Infective Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-Infective Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Infective Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Infective Medications market.
The following manufacturers are covered in this report:
- Abbott
- Astellas Pharma
- Bayer
- Bristol-Myers Squibb
- Daiichi Sankyo
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Roche
- Antivirals
- Antibacterials
- Antifungals
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 STUDY COVERAGE
1.1 Anti-Infective Medications Product Introduction
1.2 Market Segments
1.3 Key Anti-Infective Medications Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Infective Medications Market Size Growth Rate by Type
1.4.2 Antivirals
1.4.3 Antibacterials
1.4.4 Antifungals
1.5 Market by Application
1.5.1 Global Anti-Infective Medications Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Anti-Infective Medications Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-Infective Medications Industry
1.6.1.1 Anti-Infective Medications Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-Infective Medications Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Anti-Infective Medications Market Size Estimates and Forecasts
2.1.1 Global Anti-Infective Medications Revenue 2015-2026
2.1.2 Global Anti-Infective Medications Sales 2015-2026
2.2 Anti-Infective Medications Market Size by Region: 2020 Versus 2026
2.2.1 Global Anti-Infective Medications Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Infective Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTI-INFECTIVE MEDICATIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Anti-Infective Medications Sales by Manufacturers
3.1.1 Anti-Infective Medications Sales by Manufacturers (2015-2020)
3.1.2 Anti-Infective Medications Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Infective Medications Revenue by Manufacturers
3.2.1 Anti-Infective Medications Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Infective Medications Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Infective Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Medications Revenue in 2019
3.2.5 Global Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Infective Medications Price by Manufacturers
3.4 Anti-Infective Medications Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Medications Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Infective Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-Infective Medications Market Size by Type (2015-2020)
4.1.1 Global Anti-Infective Medications Sales by Type (2015-2020)
4.1.2 Global Anti-Infective Medications Revenue by Type (2015-2020)
4.1.3 Anti-Infective Medications Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Infective Medications Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Infective Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Infective Medications Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Infective Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Infective Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-Infective Medications Market Size by Application (2015-2020)
5.1.1 Global Anti-Infective Medications Sales by Application (2015-2020)
5.1.2 Global Anti-Infective Medications Revenue by Application (2015-2020)
5.1.3 Anti-Infective Medications Price by Application (2015-2020)
5.2 Anti-Infective Medications Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Infective Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Infective Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Infective Medications Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-Infective Medications by Country
6.1.1 North America Anti-Infective Medications Sales by Country
6.1.2 North America Anti-Infective Medications Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Infective Medications Market Facts & Figures by Type
6.3 North America Anti-Infective Medications Market Facts & Figures by Application
7 EUROPE
7.1 Europe Anti-Infective Medications by Country
7.1.1 Europe Anti-Infective Medications Sales by Country
7.1.2 Europe Anti-Infective Medications Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Medications Market Facts & Figures by Type
7.3 Europe Anti-Infective Medications Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Anti-Infective Medications by Region
8.1.1 Asia Pacific Anti-Infective Medications Sales by Region
8.1.2 Asia Pacific Anti-Infective Medications Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Infective Medications Market Facts & Figures by Type
8.3 Asia Pacific Anti-Infective Medications Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Anti-Infective Medications by Country
9.1.1 Latin America Anti-Infective Medications Sales by Country
9.1.2 Latin America Anti-Infective Medications Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Infective Medications Market Facts & Figures by Type
9.3 Central & South America Anti-Infective Medications Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Anti-Infective Medications by Country
10.1.1 Middle East and Africa Anti-Infective Medications Sales by Country
10.1.2 Middle East and Africa Anti-Infective Medications Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Anti-Infective Medications Products Offered
11.1.5 Abbott Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description, Business Overview and Total Revenue
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Anti-Infective Medications Products Offered
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description, Business Overview and Total Revenue
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Anti-Infective Medications Products Offered
11.3.5 Bayer Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Anti-Infective Medications Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Corporation Information
11.5.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.5.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Daiichi Sankyo Anti-Infective Medications Products Offered
11.5.5 Daiichi Sankyo Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Anti-Infective Medications Products Offered
11.6.5 GlaxoSmithKline Recent Development
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description, Business Overview and Total Revenue
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-Infective Medications Products Offered
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description, Business Overview and Total Revenue
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Anti-Infective Medications Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Description, Business Overview and Total Revenue
11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Anti-Infective Medications Products Offered
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Corporation Information
11.10.2 Roche Description, Business Overview and Total Revenue
11.10.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Roche Anti-Infective Medications Products Offered
11.10.5 Roche Recent Development
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Anti-Infective Medications Products Offered
11.1.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Anti-Infective Medications Market Estimates and Projections by Region
12.1.1 Global Anti-Infective Medications Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Infective Medications Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Infective Medications Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Infective Medications Sales Forecast (2021-2026)
12.2.2 North America: Anti-Infective Medications Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Infective Medications Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Infective Medications Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Infective Medications Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Infective Medications Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Infective Medications Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Infective Medications Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Infective Medications Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Infective Medications Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Infective Medications Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Infective Medications Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Infective Medications Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Infective Medications Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Infective Medications Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Infective Medications Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Anti-Infective Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Anti-Infective Medications Product Introduction
1.2 Market Segments
1.3 Key Anti-Infective Medications Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Infective Medications Market Size Growth Rate by Type
1.4.2 Antivirals
1.4.3 Antibacterials
1.4.4 Antifungals
1.5 Market by Application
1.5.1 Global Anti-Infective Medications Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Anti-Infective Medications Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-Infective Medications Industry
1.6.1.1 Anti-Infective Medications Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-Infective Medications Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Anti-Infective Medications Market Size Estimates and Forecasts
2.1.1 Global Anti-Infective Medications Revenue 2015-2026
2.1.2 Global Anti-Infective Medications Sales 2015-2026
2.2 Anti-Infective Medications Market Size by Region: 2020 Versus 2026
2.2.1 Global Anti-Infective Medications Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Infective Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTI-INFECTIVE MEDICATIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Anti-Infective Medications Sales by Manufacturers
3.1.1 Anti-Infective Medications Sales by Manufacturers (2015-2020)
3.1.2 Anti-Infective Medications Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Infective Medications Revenue by Manufacturers
3.2.1 Anti-Infective Medications Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Infective Medications Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Infective Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Medications Revenue in 2019
3.2.5 Global Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Infective Medications Price by Manufacturers
3.4 Anti-Infective Medications Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Medications Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Infective Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-Infective Medications Market Size by Type (2015-2020)
4.1.1 Global Anti-Infective Medications Sales by Type (2015-2020)
4.1.2 Global Anti-Infective Medications Revenue by Type (2015-2020)
4.1.3 Anti-Infective Medications Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Infective Medications Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Infective Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Infective Medications Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Infective Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Infective Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-Infective Medications Market Size by Application (2015-2020)
5.1.1 Global Anti-Infective Medications Sales by Application (2015-2020)
5.1.2 Global Anti-Infective Medications Revenue by Application (2015-2020)
5.1.3 Anti-Infective Medications Price by Application (2015-2020)
5.2 Anti-Infective Medications Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Infective Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Infective Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Infective Medications Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-Infective Medications by Country
6.1.1 North America Anti-Infective Medications Sales by Country
6.1.2 North America Anti-Infective Medications Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Infective Medications Market Facts & Figures by Type
6.3 North America Anti-Infective Medications Market Facts & Figures by Application
7 EUROPE
7.1 Europe Anti-Infective Medications by Country
7.1.1 Europe Anti-Infective Medications Sales by Country
7.1.2 Europe Anti-Infective Medications Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Medications Market Facts & Figures by Type
7.3 Europe Anti-Infective Medications Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Anti-Infective Medications by Region
8.1.1 Asia Pacific Anti-Infective Medications Sales by Region
8.1.2 Asia Pacific Anti-Infective Medications Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Infective Medications Market Facts & Figures by Type
8.3 Asia Pacific Anti-Infective Medications Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Anti-Infective Medications by Country
9.1.1 Latin America Anti-Infective Medications Sales by Country
9.1.2 Latin America Anti-Infective Medications Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Infective Medications Market Facts & Figures by Type
9.3 Central & South America Anti-Infective Medications Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Anti-Infective Medications by Country
10.1.1 Middle East and Africa Anti-Infective Medications Sales by Country
10.1.2 Middle East and Africa Anti-Infective Medications Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Anti-Infective Medications Products Offered
11.1.5 Abbott Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description, Business Overview and Total Revenue
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Anti-Infective Medications Products Offered
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description, Business Overview and Total Revenue
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Anti-Infective Medications Products Offered
11.3.5 Bayer Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Anti-Infective Medications Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Corporation Information
11.5.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.5.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Daiichi Sankyo Anti-Infective Medications Products Offered
11.5.5 Daiichi Sankyo Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Anti-Infective Medications Products Offered
11.6.5 GlaxoSmithKline Recent Development
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description, Business Overview and Total Revenue
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-Infective Medications Products Offered
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description, Business Overview and Total Revenue
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Anti-Infective Medications Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Description, Business Overview and Total Revenue
11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Anti-Infective Medications Products Offered
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Corporation Information
11.10.2 Roche Description, Business Overview and Total Revenue
11.10.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Roche Anti-Infective Medications Products Offered
11.10.5 Roche Recent Development
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Anti-Infective Medications Products Offered
11.1.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Anti-Infective Medications Market Estimates and Projections by Region
12.1.1 Global Anti-Infective Medications Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Infective Medications Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Infective Medications Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Infective Medications Sales Forecast (2021-2026)
12.2.2 North America: Anti-Infective Medications Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Infective Medications Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Infective Medications Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Infective Medications Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Infective Medications Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Infective Medications Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Infective Medications Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Infective Medications Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Infective Medications Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Infective Medications Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Infective Medications Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Infective Medications Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Infective Medications Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Infective Medications Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Infective Medications Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Infective Medications Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Anti-Infective Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Anti-Infective Medications Market Segments
Table 2. Ranking of Global Top Anti-Infective Medications Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Infective Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antivirals
Table 5. Major Manufacturers of Antibacterials
Table 6. Major Manufacturers of Antifungals
Table 7. COVID-19 Impact Global Market: (Four Anti-Infective Medications Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Anti-Infective Medications Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact
Table 12. Global Anti-Infective Medications Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Anti-Infective Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Anti-Infective Medications Sales by Regions 2015-2020 (K Units)
Table 15. Global Anti-Infective Medications Sales Market Share by Regions (2015-2020)
Table 16. Global Anti-Infective Medications Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Anti-Infective Medications Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Anti-Infective Medications Sales Share by Manufacturers (2015-2020)
Table 19. Global Anti-Infective Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Anti-Infective Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Medications as of 2019)
Table 21. Anti-Infective Medications Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Anti-Infective Medications Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Anti-Infective Medications Price (2015-2020) (USD/Unit)
Table 24. Anti-Infective Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anti-Infective Medications Product Type
Table 26. Date of International Manufacturers Enter into Anti-Infective Medications Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 29. Global Anti-Infective Medications Sales Share by Type (2015-2020)
Table 30. Global Anti-Infective Medications Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Anti-Infective Medications Revenue Share by Type (2015-2020)
Table 32. Anti-Infective Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 34. Global Anti-Infective Medications Sales Share by Application (2015-2020)
Table 35. North America Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 36. North America Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 37. North America Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 39. North America Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 40. North America Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 41. North America Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 42. North America Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 43. Europe Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 44. Europe Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 45. Europe Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 47. Europe Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 48. Europe Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 50. Europe Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Anti-Infective Medications Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Anti-Infective Medications Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Anti-Infective Medications Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Anti-Infective Medications Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 59. Latin America Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 60. Latin America Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 63. Latin America Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 64. Latin America Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 65. Latin America Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 66. Latin America Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Major Businesses
Table 77. Abbott Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Abbott Product
Table 79. Abbott Recent Development
Table 80. Astellas Pharma Corporation Information
Table 81. Astellas Pharma Description and Major Businesses
Table 82. Astellas Pharma Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Astellas Pharma Product
Table 84. Astellas Pharma Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Major Businesses
Table 92. Bristol-Myers Squibb Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Daiichi Sankyo Corporation Information
Table 96. Daiichi Sankyo Description and Major Businesses
Table 97. Daiichi Sankyo Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Daiichi Sankyo Product
Table 99. Daiichi Sankyo Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Major Businesses
Table 102. GlaxoSmithKline Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Novartis Product
Table 114. Novartis Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Pfizer Product
Table 119. Pfizer Recent Development
Table 120. Roche Corporation Information
Table 121. Roche Description and Major Businesses
Table 122. Roche Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Roche Product
Table 124. Roche Recent Development
Table 125. Global Anti-Infective Medications Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Anti-Infective Medications Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Anti-Infective Medications Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Anti-Infective Medications Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Anti-Infective Medications Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Anti-Infective Medications Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Anti-Infective Medications Players
Table 143. Anti-Infective Medications Customers List
Table 144. Anti-Infective Medications Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Anti-Infective Medications Market Segments
Table 2. Ranking of Global Top Anti-Infective Medications Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Infective Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antivirals
Table 5. Major Manufacturers of Antibacterials
Table 6. Major Manufacturers of Antifungals
Table 7. COVID-19 Impact Global Market: (Four Anti-Infective Medications Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Anti-Infective Medications Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact
Table 12. Global Anti-Infective Medications Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Anti-Infective Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Anti-Infective Medications Sales by Regions 2015-2020 (K Units)
Table 15. Global Anti-Infective Medications Sales Market Share by Regions (2015-2020)
Table 16. Global Anti-Infective Medications Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Anti-Infective Medications Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Anti-Infective Medications Sales Share by Manufacturers (2015-2020)
Table 19. Global Anti-Infective Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Anti-Infective Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Medications as of 2019)
Table 21. Anti-Infective Medications Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Anti-Infective Medications Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Anti-Infective Medications Price (2015-2020) (USD/Unit)
Table 24. Anti-Infective Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anti-Infective Medications Product Type
Table 26. Date of International Manufacturers Enter into Anti-Infective Medications Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 29. Global Anti-Infective Medications Sales Share by Type (2015-2020)
Table 30. Global Anti-Infective Medications Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Anti-Infective Medications Revenue Share by Type (2015-2020)
Table 32. Anti-Infective Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 34. Global Anti-Infective Medications Sales Share by Application (2015-2020)
Table 35. North America Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 36. North America Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 37. North America Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 39. North America Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 40. North America Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 41. North America Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 42. North America Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 43. Europe Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 44. Europe Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 45. Europe Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 47. Europe Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 48. Europe Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 50. Europe Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Anti-Infective Medications Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Anti-Infective Medications Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Anti-Infective Medications Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Anti-Infective Medications Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 59. Latin America Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 60. Latin America Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 63. Latin America Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 64. Latin America Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 65. Latin America Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 66. Latin America Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Anti-Infective Medications Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Anti-Infective Medications Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Infective Medications Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Anti-Infective Medications Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Anti-Infective Medications Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Anti-Infective Medications Sales Market Share by Application (2015-2020)
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Major Businesses
Table 77. Abbott Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Abbott Product
Table 79. Abbott Recent Development
Table 80. Astellas Pharma Corporation Information
Table 81. Astellas Pharma Description and Major Businesses
Table 82. Astellas Pharma Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Astellas Pharma Product
Table 84. Astellas Pharma Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Major Businesses
Table 92. Bristol-Myers Squibb Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Daiichi Sankyo Corporation Information
Table 96. Daiichi Sankyo Description and Major Businesses
Table 97. Daiichi Sankyo Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Daiichi Sankyo Product
Table 99. Daiichi Sankyo Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Major Businesses
Table 102. GlaxoSmithKline Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Novartis Product
Table 114. Novartis Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Pfizer Product
Table 119. Pfizer Recent Development
Table 120. Roche Corporation Information
Table 121. Roche Description and Major Businesses
Table 122. Roche Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Roche Product
Table 124. Roche Recent Development
Table 125. Global Anti-Infective Medications Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Anti-Infective Medications Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Anti-Infective Medications Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Anti-Infective Medications Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Anti-Infective Medications Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Anti-Infective Medications Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Anti-Infective Medications Players
Table 143. Anti-Infective Medications Customers List
Table 144. Anti-Infective Medications Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Anti-Infective Medications Product Picture
Figure 2. Global Anti-Infective Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Antivirals Product Picture
Figure 4. Antibacterials Product Picture
Figure 5. Antifungals Product Picture
Figure 6. Global Anti-Infective Medications Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Online Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Anti-Infective Medications Report Years Considered
Figure 11. Global Anti-Infective Medications Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Infective Medications Sales 2015-2026 (K Units)
Figure 13. Global Anti-Infective Medications Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anti-Infective Medications Sales Market Share by Region (2015-2020)
Figure 15. Global Anti-Infective Medications Sales Market Share by Region in 2019
Figure 16. Global Anti-Infective Medications Revenue Market Share by Region (2015-2020)
Figure 17. Global Anti-Infective Medications Revenue Market Share by Region in 2019
Figure 18. Global Anti-Infective Medications Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-Infective Medications Revenue in 2019
Figure 20. Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anti-Infective Medications Sales Market Share by Type (2015-2020)
Figure 22. Global Anti-Infective Medications Sales Market Share by Type in 2019
Figure 23. Global Anti-Infective Medications Revenue Market Share by Type (2015-2020)
Figure 24. Global Anti-Infective Medications Revenue Market Share by Type in 2019
Figure 25. Global Anti-Infective Medications Market Share by Price Range (2015-2020)
Figure 26. Global Anti-Infective Medications Sales Market Share by Application (2015-2020)
Figure 27. Global Anti-Infective Medications Sales Market Share by Application in 2019
Figure 28. Global Anti-Infective Medications Revenue Market Share by Application (2015-2020)
Figure 29. Global Anti-Infective Medications Revenue Market Share by Application in 2019
Figure 30. North America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anti-Infective Medications Sales Market Share by Country in 2019
Figure 33. North America Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 34. U.S. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anti-Infective Medications Market Share by Type in 2019
Figure 39. North America Anti-Infective Medications Market Share by Application in 2019
Figure 40. Europe Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anti-Infective Medications Sales Market Share by Country in 2019
Figure 43. Europe Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 44. Germany Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anti-Infective Medications Market Share by Type in 2019
Figure 55. Europe Anti-Infective Medications Market Share by Application in 2019
Figure 56. Asia Pacific Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anti-Infective Medications Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anti-Infective Medications Revenue Market Share by Region in 2019
Figure 60. China Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Anti-Infective Medications Market Share by Type in 2019
Figure 83. Asia Pacific Anti-Infective Medications Market Share by Application in 2019
Figure 84. Latin America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Anti-Infective Medications Sales Market Share by Country in 2019
Figure 87. Latin America Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 88. Mexico Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Anti-Infective Medications Market Share by Type in 2019
Figure 95. Latin America Anti-Infective Medications Market Share by Application in 2019
Figure 96. Middle East and Africa Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anti-Infective Medications Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 100. Turkey Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Anti-Infective Medications Market Share by Type in 2019
Figure 107. Middle East and Africa Anti-Infective Medications Market Share by Application in 2019
Figure 108. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Figure 1. Anti-Infective Medications Product Picture
Figure 2. Global Anti-Infective Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Antivirals Product Picture
Figure 4. Antibacterials Product Picture
Figure 5. Antifungals Product Picture
Figure 6. Global Anti-Infective Medications Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Online Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Anti-Infective Medications Report Years Considered
Figure 11. Global Anti-Infective Medications Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Infective Medications Sales 2015-2026 (K Units)
Figure 13. Global Anti-Infective Medications Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anti-Infective Medications Sales Market Share by Region (2015-2020)
Figure 15. Global Anti-Infective Medications Sales Market Share by Region in 2019
Figure 16. Global Anti-Infective Medications Revenue Market Share by Region (2015-2020)
Figure 17. Global Anti-Infective Medications Revenue Market Share by Region in 2019
Figure 18. Global Anti-Infective Medications Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-Infective Medications Revenue in 2019
Figure 20. Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anti-Infective Medications Sales Market Share by Type (2015-2020)
Figure 22. Global Anti-Infective Medications Sales Market Share by Type in 2019
Figure 23. Global Anti-Infective Medications Revenue Market Share by Type (2015-2020)
Figure 24. Global Anti-Infective Medications Revenue Market Share by Type in 2019
Figure 25. Global Anti-Infective Medications Market Share by Price Range (2015-2020)
Figure 26. Global Anti-Infective Medications Sales Market Share by Application (2015-2020)
Figure 27. Global Anti-Infective Medications Sales Market Share by Application in 2019
Figure 28. Global Anti-Infective Medications Revenue Market Share by Application (2015-2020)
Figure 29. Global Anti-Infective Medications Revenue Market Share by Application in 2019
Figure 30. North America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anti-Infective Medications Sales Market Share by Country in 2019
Figure 33. North America Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 34. U.S. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anti-Infective Medications Market Share by Type in 2019
Figure 39. North America Anti-Infective Medications Market Share by Application in 2019
Figure 40. Europe Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anti-Infective Medications Sales Market Share by Country in 2019
Figure 43. Europe Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 44. Germany Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anti-Infective Medications Market Share by Type in 2019
Figure 55. Europe Anti-Infective Medications Market Share by Application in 2019
Figure 56. Asia Pacific Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anti-Infective Medications Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anti-Infective Medications Revenue Market Share by Region in 2019
Figure 60. China Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Anti-Infective Medications Market Share by Type in 2019
Figure 83. Asia Pacific Anti-Infective Medications Market Share by Application in 2019
Figure 84. Latin America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Anti-Infective Medications Sales Market Share by Country in 2019
Figure 87. Latin America Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 88. Mexico Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Anti-Infective Medications Market Share by Type in 2019
Figure 95. Latin America Anti-Infective Medications Market Share by Application in 2019
Figure 96. Middle East and Africa Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anti-Infective Medications Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country in 2019
Figure 100. Turkey Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Anti-Infective Medications Market Share by Type in 2019
Figure 107. Middle East and Africa Anti-Infective Medications Market Share by Application in 2019
Figure 108. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
